procyanidin b2 has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, YH; He, XX; Jing, YX; Li, HX; Ma, XL; Sun, XH; Xi, YM; Xue, SL | 1 |
1 other study(ies) available for procyanidin b2 and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Topics: Drugs, Chinese Herbal; ErbB Receptors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Network Pharmacology | 2023 |